Spots Global Cancer Trial Database for cisplatin
Every month we try and update this database with for cisplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck | NCT00402545 | Head and Neck N... | Cetuximab Docetaxel Cisplatin 5-Fluorouracil | 18 Years - | Dana-Farber Cancer Institute | |
| Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer | NCT00001499 | Carcinoma, Non-... Lung Neoplasms | paclitaxel cisplatin chest radiother... | - | National Institutes of Health Clinical Center (CC) | |
| DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | NCT00083681 | Multiple Myelom... | Thalidomide Dexamethasone Cytoxan Etoposide Cisplatin G-CSF | 18 Years - | University of Arkansas | |
| An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease | NCT03770299 | Non-Small Cell ... Non-Small-Cell ... Circulating Tum... | Nivolumab Vinorelbine Gemcitabine Docetaxel Pemetrexed Cisplatin Carboplatin Paclitaxel Observation | 18 Years - | Bristol-Myers Squibb | |
| Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | NCT00090909 | Lymphoma | cisplatin dexamethasone gemcitabine hyd... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | NCT00639769 | Head and Neck C... | cisplatin irinotecan hydr... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Bristol Bladder Trial | NCT01616875 | Infiltrating Bl... | Cabazitaxel + C... | 18 Years - | University Hospitals Bristol and Weston NHS Foundation Trust | |
| Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | NCT00003809 | Head and Neck C... | cetuximab cisplatin | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma | NCT00002539 | Sarcoma | filgrastim cisplatin doxorubicin hyd... conventional su... | - 40 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC | NCT03557112 | Nasopharyngeal ... | Nimotuzumab Cisplatin | 18 Years - 70 Years | Guiyang Medical University | |
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | NCT01873326 | Germ Cell Tumor... | Paclitaxel Ifosfamide Cisplatin Mesna Bleomycin Etoposide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours | NCT01861496 | Phase 1: Advanc... Phase 2 Part: M... | LiPlaCis | 18 Years - | Allarity Therapeutics | |
| A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers | NCT04328844 | Solid Tumor, Ad... Non-Hodgkin Lym... NSCLC Myelofibrosis Uveal Melanoma | IOA-244 Avelumab Inject... Pemetrexed Cisplatin Ruxolitinib | 18 Years - | iOnctura | |
| Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer | NCT00033449 | Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... | gefitinib radiation thera... cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer | NCT01642251 | Extensive Stage... Large Cell Lung... Neuroendocrine ... Small Cell Carc... Stage IV Non-Sm... | Cisplatin Etoposide Veliparib Placebo | 18 Years - | National Cancer Institute (NCI) | |
| Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension | NCT04882241 | Gastric Cancer Gastroesophagea... | Pembrolizumab Placebo Cisplatin Capecitabine 5-fluorouracil Docetaxel Oxaliplatin Leucovorin | 18 Years - | Merck Sharp & Dohme LLC | |
| Biomarkers in Patients With Head and Neck Cancer | NCT01466257 | Head and Neck C... | cetuximab cisplatin DNA analysis gene expression... mutation analys... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling | NCT01868022 | Neoplasms | GSK3052230 paclitaxel carboplatin docetaxel pemetrexed cisplatin | 18 Years - | GlaxoSmithKline | |
| Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer | NCT04223856 | Urothelial Canc... | Enfortumab vedo... Pembrolizumab Cisplatin Carboplatin Gemcitabine | 18 Years - | Astellas Pharma Inc | |
| A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation | NCT05789082 | Non-Small Cell ... | Divarasib Pembrolizumab Carboplatin Cisplatin Pemetrexed | 18 Years - | Hoffmann-La Roche | |
| TRACE: Tirapazamine-Radiation And Cisplatin Evaluation | NCT00174837 | Head and Neck S... | Tirapazamine Cisplatin | 18 Years - | Sanofi | |
| Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer | NCT00160875 | Esophageal Canc... | Irinotecan hydr... Cisplatin | 18 Years - | University Health Network, Toronto | |
| Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | NCT01015339 | Advanced Gastri... | Paclitaxel capecitabine capecitabine cisplatin | 18 Years - | Peking University | |
| High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | NCT00002722 | Gastric Cancer | cisplatin fluorouracil leucovorin calc... | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | NCT00001569 | Carcinoma Peritoneal Neop... | Cisplatin Paclitaxel 5-FU | - | National Institutes of Health Clinical Center (CC) | |
| Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) | NCT00452634 | Small Cell Lung... | Irinotecan Cisplatin Simvastatin | 18 Years - | National Cancer Center, Korea | |
| A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors | NCT06057038 | Malignant Solid... | GEN1042 Pembrolizumab Cisplatin Carboplatin 5-Fluorouracil | 18 Years - | Genmab | |
| Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | NCT04361409 | Head and Neck S... | Rituximab Cisplatin Gemcitabine | 20 Years - 65 Years | China Medical University Hospital | |
| Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS) | NCT02082522 | Hilar Cholangio... | Photodynamic th... Stenting proced... Chemotherapy re... | 18 Years - | Concordia Laboratories Inc. | |
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer | NCT03101566 | Biliary Tract N... | Gemcitabine Cisplatin Ipilimumab Nivolumab | 18 Years - | University of Michigan Rogel Cancer Center | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | NCT00004003 | Pancreatic Canc... | cisplatin fluorouracil gemcitabine hyd... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer | NCT02954536 | Esophageal Canc... Gastric Cancer | pembrolizumab trastuzumab capecitabine cisplatin Oxaliplatin 5-Fluorouracil | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. | NCT04229459 | Esophageal Squa... | Cisplatin 5-FU Radiation thera... Cetuximab Nivolumab | 18 Years - | Rabin Medical Center | |
| Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | NCT00003364 | Lung Cancer | cisplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... radiation thera... | - 74 Years | National Cancer Institute (NCI) | |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT04222972 | RET-fusion Non ... Lung Neoplasm Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Disea... Head and Neck N... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Germ... Neoplasms, Nerv... | Pralsetinib Carboplatin Cisplatin Pemetrexed Pembrolizumab Gemcitabine Paclitaxel Nab-Paclitaxel | 18 Years - | Hoffmann-La Roche | |
| Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer | NCT04884906 | Locally Advance... | Camrelizumab radiotherapy Albumin Paclita... Cisplatin | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer | NCT01046461 | Solid Tumour Postoperative N... | Ramosetron, Apr... | 18 Years - 75 Years | Hallym University Medical Center | |
| Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil | NCT00400205 | Squamous Cell C... Oral Cancer | Docetaxel Cisplatin 5-fluorouracil | 18 Years - | Emory University | |
| Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | NCT04437329 | Nasopharyngeal ... | Docetaxel, neda... Docetaxel, cisp... Nedaplatin Cisplatin Intensity modul... | 18 Years - 65 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer | NCT04677504 | Biliary Tract C... | Atezolizumab Bevacizumab Placebo Cisplatin Gemcitabine | 18 Years - | Hoffmann-La Roche | |
| A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma | NCT05967182 | Cholangiocarcin... | Pembrolizumab Gemcitabine Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0) | NCT00563862 | Nasopharyngeal ... Carcinoma, Squa... | Conventional RT Accelerated RT Cisplatin 5-fluorouracil | - 70 Years | Hospital Authority, Hong Kong | |
| Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma | NCT02801487 | Nasopharyngeal ... | Carbon ion radi... Cisplatin | 18 Years - 70 Years | Shanghai Proton and Heavy Ion Center | |
| Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed | NCT00003053 | Lung Cancer | cisplatin etoposide adjuvant therap... | - 70 Years | National Cancer Institute (NCI) | |
| Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer | NCT00004077 | Testicular Germ... | cisplatin ifosfamide paclitaxel | 16 Years - 64 Years | National Cancer Institute (NCI) | |
| Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma | NCT02088515 | Squamous Cell C... | Nedaplatin Cisplatin Docetaxel | 18 Years - 75 Years | Jiangsu Simcere Pharmaceutical Co., Ltd. | |
| Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer | NCT00063999 | Recurrent Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri... | Carboplatin Cisplatin Doxorubicin Hyd... Filgrastim Laboratory Biom... Paclitaxel Pegfilgrastim Quality-of-Life... | 18 Years - | GOG Foundation | |
| Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | NCT00003941 | Mediastinal Can... Metastatic Canc... Testicular Germ... | bleomycin sulfa... filgrastim cisplatin etoposide ifosfamide bone marrow abl... peripheral bloo... | 16 Years - 50 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study | NCT03881111 | Esophageal Neop... | Pembrolizumab Placebo Cisplatin 5-FU | 18 Years - | Merck Sharp & Dohme LLC | |
| Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma | NCT01540136 | Nasopharyngeal ... | Nedaplatin Cisplatin | 18 Years - 65 Years | Sun Yat-sen University | |
| Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT02325401 | Head and Neck C... | Metformin Cisplatin Radiation Thera... | 18 Years - | University of Cincinnati | |
| Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-naïve Patients With Locally Advanced or Metastatic Urothelial Carcinoma | NCT00714948 | Bladder Cancer URINARY BLADDER | gemcitabine and... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) | NCT00995761 | Non-small Cell ... | Docetaxel and C... | 18 Years - 75 Years | Gyeongsang National University Hospital | |
| Chemotherapy in Treating Children With Liver Cancer | NCT00003912 | Liver Cancer | carboplatin cisplatin doxorubicin hyd... conventional su... | - 16 Years | National Cancer Institute (NCI) | |
| Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer | NCT01661790 | Malignant Pleur... | Bevacizumab Cisplatin | 18 Years - 85 Years | Chinese PLA General Hospital | |
| Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy | NCT02432365 | Cervical Cancer | paclitaxel cisplatin Radical hystere... | 35 Years - 70 Years | Chang Gung Memorial Hospital | |
| Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | NCT02934503 | Small Cell Lung... | Pembrolizumab Cisplatin Carboplatin Etoposide Radiation thera... | 19 Years - | NYU Langone Health | |
| Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer | NCT00192036 | Non Small Cell ... | gemcitabine cisplatin radiation | 18 Years - | Eli Lilly and Company | |
| Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer | NCT03367871 | Cervical Cancer | Pembrolizumab Paclitaxel Cisplatin Carboplatin Bevacizumab | 18 Years - | University of Miami | |
| Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer | NCT00964626 | Ovarian Cancer | cisplatin paclitaxel | 18 Years - 72 Years | National Cancer Institute (NCI) | |
| A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer | NCT00731380 | Head and Neck C... | ABI-007 | 18 Years - | University Health Network, Toronto | |
| A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy | NCT00590967 | Cervical Cancer | IMRT extended f... Brachytherapy Cisplatin | 18 Years - | Washington University School of Medicine | |
| S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery | NCT00659113 | Esophageal Canc... | cisplatin tegafur-gimerac... cytology specim... endoscopic biop... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC | NCT03629925 | Squamous NSCLC | Sintilimab Gemcitabine Cisplatin Placebo Carboplatin | 18 Years - 75 Years | Innovent Biologics (Suzhou) Co. Ltd. | |
| GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer | NCT01918306 | Estrogen Recept... Human Epidermal... Triple Negative... Recurrent Breas... Stage IV Breast... Triple-negative... | cisplatin laboratory biom... pharmacological... dynamic contras... GDC -0941 | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC | NCT05516589 | Head and Neck S... | Nab-paclitaxel Cisplatin Tislelizumab Afatinib | 18 Years - | West China Hospital | |
| A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer | NCT00001426 | Ovarian Neoplas... | Cyclophosphamid... Paclitaxel Cisplatin G-CSF | - | National Institutes of Health Clinical Center (CC) | |
| RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN | NCT01009346 | Head and Neck C... | RAD001 Cetuximab Cisplatin Carboplatin | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer | NCT00109850 | Esophageal Canc... | cetuximab cisplatin irinotecan hydr... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma | NCT01829178 | Upper GI Cancer Cisplatin Adver... | Silymarin Placebo chemotherapy | 18 Years - 70 Years | Tehran University of Medical Sciences | |
| Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma | NCT03984357 | Nasopharyngeal ... | PD-1 blocking a... Gemcitabine Cisplatin Intensity-modul... | 18 Years - 65 Years | Sun Yat-sen University | |
| Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | NCT00006389 | Stage III Gastr... Stage IV Gastri... | bryostatin 1 cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy | NCT02957266 | Cervical Cancer | Volumetric Arc ... Interstitial br... Cisplatin Gemcitabine PIK3CA KRAS BRAF RRM1 | 18 Years - 70 Years | The National Center of Oncology, Azerbaijan | |
| Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas | NCT02120807 | Stage IV Lung A... | Certolizumab cisplatin pemetrexed | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Taxotere New Indication - Gastric Cancer Treatment Registration Trial | NCT00811447 | Stomach Neoplas... | 5-fluorouracil Cisplatin Docetaxel | 18 Years - 70 Years | Sanofi | |
| Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas | NCT00490399 | Biliary Tract C... | gemcitabine cisplatin | 20 Years - 70 Years | Eli Lilly and Company | |
| Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer | NCT03158129 | Stage I Lung No... Stage IA Lung N... Stage IB Lung N... Stage II Lung N... Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... | Carboplatin Cisplatin Docetaxel Ipilimumab Nivolumab Pemetrexed | 18 Years - | M.D. Anderson Cancer Center | |
| A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer | NCT00123318 | Gastric Cancer | epirubicin cisplatin 5-fluorouracil Radiotherapy | 18 Years - | Trans Tasman Radiation Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
